Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06UOU
|
|||
| Former ID |
DNCL002168
|
|||
| Drug Name |
MGA271
|
|||
| Indication | Metastatic cancer [ICD-11: 2D50-2E2Z; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
MacroGenics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | B7 homolog 3 (CD276) | Target Info | Modulator | [2] |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01918930) Tissue Procurement Substudy for Participants in Study CP-MGA271-01. U.S. National Institutes of Health. | |||
| REF 2 | T Cell Coinhibition and Immunotherapy in Human Breast Cancer. Discov Med. 2012 October; 14(77): 229-236. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.